BioGaia AB (publ)
BGLAF
$8.87
-$0.8517-8.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.52M | 7.59M | 3.51M | 10.38M | 11.72M |
| Total Depreciation and Amortization | 581.10K | 677.20K | 609.60K | 575.10K | 552.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -518.20K | -1.50M | 5.82M | 609.70K | -473.30K |
| Change in Net Operating Assets | -4.23M | 2.70M | -339.60K | -425.70K | -6.81M |
| Cash from Operations | 3.35M | 9.47M | 9.61M | 11.14M | 5.00M |
| Capital Expenditure | -63.70K | 5.00K | -269.20K | -208.90K | -844.00K |
| Sale of Property, Plant, and Equipment | -- | 7.40K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.80K | -35.80K | -200.00 | -700.00 | -100.00 |
| Cash from Investing | -65.40K | -23.40K | -269.40K | -209.60K | -844.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.80M | -2.54M | -2.19M | -2.35M | -2.28M |
| Issuance of Common Stock | -- | 0.00 | 20.82M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -65.17M | -- |
| Other Financing Activities | -- | -504.91M | -4.40M | -- | -- |
| Cash from Financing | -168.90K | -235.30K | 1.37M | -65.39M | -219.50K |
| Foreign Exchange rate Adjustments | -741.60K | 930.10K | -440.40K | -132.10K | 609.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.37M | 10.14M | 10.26M | -54.59M | 4.54M |